High-impact translational research is a top priority at Cleveland Clinic Cancer Center.
Cleveland Clinic physicians and scientists have developed new treatments for, and uncovered key information about, cancer cells that have resulted in significant changes in the way patients are screened, diagnosed and treated. In recognition of these and other contributions, U.S. News and World Report has ranked Cleveland Clinic as one of the top 10 cancer centers in the nation for the last several years.
At Cleveland Clinic, we believe in “Care that's Personal; Research that's Revolutionary.” We are home to one of the most robust cancer research enterprises in the United States, encompassing basic, clinical and translational research.
Regrettably, the extramural funding to support such projects is harder and harder to obtain. We are extremely fortunate to benefit from VeloSano. Every mile that our participants ride and every dollar that our donors give is a reminder of our obligation to leverage their incredible generosity, by pursuing research that will make a difference in our patients’ lives.
Below you will find the Annual Reports from years one and two, as well as additional details about how the funds are allocated and the different focus areas. It's inspiring to see that the dollars raised in two short years are already making an impact.
Participating in VeloSano is fun, exciting and immensely gratifying, and I look forward to seeing you in Cleveland for VeloSano 3: July 29–31 - Thank You!
Brian J. Bolwell, MD, FACP
Chairman, Taussig Cancer Institute at Cleveland Clinic
Medical Chairman, VeloSano